Search by Drug Name or NDC
NDC 69489-0411-30 Qbrexza 2.4 g/100g Details
Qbrexza 2.4 g/100g
Qbrexza is a TOPICAL CLOTH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Journey Medical Corporation. The primary component is GLYCOPYRRONIUM TOSYLATE.
MedlinePlus Drug Summary
Topical glycopyrronium is used to treat excessive underarm sweating in adults and children 9 years of age and older. Topical glycopyrronium is in a class of medications called anticholinergics. It works by blocking the activity of a certain natural substance that triggers the sweat glands to produce sweat.
Related Packages: 69489-0411-30Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Glycopyrronium Topical
Product Information
| NDC | 69489-0411 |
|---|---|
| Product ID | 69489-411_78796126-f6ed-42e3-b40d-ea5723b89516 |
| Associated GPIs | 90970030204320 |
| GCN Sequence Number | 078624 |
| GCN Sequence Number Description | glycopyrronium tosylate TOWELETTE 2.4 % TOPICAL |
| HIC3 | L8C |
| HIC3 Description | TOPICAL ANTICHOLINERGIC HYPERHIDROSIS TX AGENTS |
| GCN | 44983 |
| HICL Sequence Number | 045086 |
| HICL Sequence Number Description | GLYCOPYRRONIUM TOSYLATE |
| Brand/Generic | Brand |
| Proprietary Name | Qbrexza |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | glycopyrronium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CLOTH |
| Route | TOPICAL |
| Active Ingredient Strength | 2.4 |
| Active Ingredient Units | g/100g |
| Substance Name | GLYCOPYRRONIUM TOSYLATE |
| Labeler Name | Journey Medical Corporation |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA210361 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69489-0411-30 (69489041130)
| NDC Package Code | 69489-411-30 |
|---|---|
| Billing NDC | 69489041130 |
| Package | 30 POUCH in 1 CARTON (69489-411-30) / 2.8 g in 1 POUCH (69489-411-01) |
| Marketing Start Date | 2021-12-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 20.7176 |
| Pricing Unit | EA |
| Effective Date | 2022-04-29 |
| NDC Description | QBREXZA 2.4% CLOTH |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 2 |
| Classification for Rate Setting | B |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis